Skip to main content

Advertisement

Table 1 Clinical and laboratory characteristics according to survival

From: Contrasting effects of preexisting hyperglycemia and higher body size on hospital mortality in critically ill patients: a prospective cohort study

  Survivors Nonsurvivors P
  (n = 113) (n = 86)
Age (years) 56 ± 17.4 61 ± 17 0.052
Males 65 (57. 5) 46 (53.5) 0.570
Days in hospital before ICU admission 2.5 (1–8) 6 (1–16) <0.001
APACHE II 17.6 ± 7.9 24.8 ± 7.8 <0.001
SOFA 5 (2– 9) 8 (6 –13) <0.001
Comorbidities    
  COPD 20 (18) 12 (14) 0.443
  CHF 12 (10.8) 9 (10.5) 0.938
  HIV 6 (5.4) 7 (8.1) 0.443
Body mass index (kg/m2) 27.2 ± 7.3 24.7 ± 5 0.031
History of DM 26 (23) 24 (27.9) 0.430
Glucose tolerance    0.359
  Normal 51 (45.1) 41 (47.7)  
  Prediabetes 40 (35.4) 23 (26.7)  
  Diabetes 22 (19.5) 22 (25.6)  
HbA1c (%) 5.7 (5.3–6.3) 5.8 (5.2–6.5) 0.729
Serum glucose (mg/dL) 122 (99–160) 120 (95–167) 0.909
Lactate (mg/dL) 9.0 (6.3–15.3) 18 (0–35) <0.001
C-reactive protein (mg/dL) 87 (27.5–150.4) 102 (44 –234) 0.067
Mechanical ventilation 69 (61.1) 68 (79.1) 0.008
Hemodialysis 15 (13.3) 30 (34.9) <0.001
Vasopressor support 39 (34.5) 64 (74.4%) <0.001
  1. Data are expressed as mean ± standard deviation, median (interquartile range), or n (%). COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; HIV, human immunodeficiency virus. To convert glucose from mg/dl to mmol/L, multiply by the factor 0.005. To convert lactate from mg/dL to mmol/L, multiply by the factor 0.111.